Teva Launches Two Digital Inhalers in the U.S., AirDuo® Digihaler® (fluticasone propionate and salmeterol) Inhalation Powder and ArmonAir® Digihaler® (fluticasone propionate) Inhalation Powder | Business Wire
Teva Pharmaceuticals Ireland today launches the first national respiratory inhaler recycling pilot
Why Teva Pharmaceutical Stock Is Sliding Today | The Motley Fool
Why Teva Pharmaceutical Stock Is Jumping Today | The Motley Fool
/arc-anglerfish-arc2-prod-pmn.s3.amazonaws.com/public/QLOB6IH57ZGW3NM55HWQDLO2BU.jpg "Teva Pharmaceutical Industries names a new CEO")
Teva Pharmaceutical Industries names a new CEO
Teva to Launch New Growth Strategy at Investor Day
FDA approves a generic version of Teva Pharmaceutical's best-selling drug; company shares tumble
Drug Maker Teva to Pay Over $500 Million in New York Drug Case Settlement - The New York Times
Teva® Announces the Arrival of its Latest Collection for Fall 2022
Do Analysts Expect Teva Pharmaceutical Industries Ltd (TEVA) Stock to Rise After It Has Gained 10.21% in a Month?
Teva Pharmaceuticals: Israeli drugmaker to cut 14,000 jobs - BBC News
TEVA Plunges on Q1 Results - TipRanks.com
Teva CEO Richard Francis, after 120 days at the helm, preps grand strategic reveal
Articles about Teva Pharmaceuticals, Inc.
Teva Pharmaceutical Industries Ltd. - Home | Facebook
Teva Announces Launch of Generic Epiduo® in the United States | World Pharma Today
teva News and latest stories | The Jerusalem Post
Teva Pharmaceutical Initiated at Market Perform at BMO - TheStreet
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults
Teva Pharmaceutical to Replace CEO Kare Schultz - WSJ
Teva Pharmaceutical Industries and opioid settlement: What to know
Teva announces debt recycling measures - Globes
Teva, workers sign accord on Jerusalem factory closure terms | The Times of Israel
Why Is Teva Pharmaceuticals (TEVA) Stock Up Today? | InvestorPlace
Teva to acquire Allergan for $40B
Teva Reaches Tentative $4.25 Billion Settlement Over Opioids - The New York Times
